Childhood cancers: open trials in Belgium

84 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven
Registry updated 2026-11-06
NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Antwerp University Hospital, Edegem · UZ Leuven, Leuven
Registry updated 2026-11-06
NCT05862285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Trial Treatment · Phase 3 · Hoffmann-La Roche
GHdC Site Les Viviers, Charleroi · AZ Groeninge, Kortrijk · UZ Leuven Gasthuisberg, Leuven
Registry updated 2026-11-06
NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-11-04
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Institut Jules Bordet, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-11-02
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-30
NCT07630974
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-30
NCT07700758
A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-30
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
Research · EMD Serono Research & Development Institute, Inc.
JESSA Ziekenhuis, Hasselt · AZ Delta, Roeselare · AZ Nikolaas, Sint-Niklaas · Cliniques UCL de Mont-Godinne (7077), Yvoir
Registry updated 2026-10-29
NCT07474025
Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot Study
Research · Jules Bordet Institute
Institut Jules Bordet, Brussels · Hub Bordet, Brussels
Registry updated 2026-10-26
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Ghent university hospital, Ghent
Registry updated 2026-10-26
2022-501454-11-00
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Trial Treatment · Phase 3 · GPOH gGmbH
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-21
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Cliniques Universitaires Saint-Luc (CUSL), Brussels · UZ Leuven, Leuven
Registry updated 2026-10-21
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-21
NCT07291102
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
Trial Treatment · Phase 3 · Nationwide Children's Hospital
University Childrens Hospital Queen Fabiola, Brussels · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-20
2022-501180-40-00
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Trial Treatment · Phase 3 · GPOH gGmbH
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-19
NCT03394365
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Trial Treatment · Phase 3 · Pierre Fabre Medicament
Universitair Ziekenhuis Leuven (Adults and Pediatrics), Leuven · Centre Hospitalier Universitaire de Liège Site Sart Tilman (Adults and Pediatrics), Liège
Registry updated 2026-10-19
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Centre Hospitalier Regional de la Citadelle, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-19
2023-506546-23-00
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven
Registry updated 2026-10-16
NCT01356290
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Trial Treatment · Phase 2 · Medical University of Vienna
Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · CHC MontLégia, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-13
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Ghent university hospital, Ghent
Registry updated 2026-10-09
NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Xencor, Inc.
AZ Groeninge, Kortrijk · UZ Leuven, Leuven · CHU de Liège, Liège
Registry updated 2026-10-09
NCT07865117
Development of a Digital Personalised Nutrition Tool for Adolescents Undergoing Cancer Treatment
Trial Treatment · KU Leuven
University Hospitals Leuven (UZ Leuven), Leuven
Registry updated 2026-10-08
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Antwerp University Hospital, Edegem · Algemeen Ziekenhuis Groeninge, Kortrijk · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Vitaz, Sint-Niklaas · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-10-06
NCT06941272
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Universitair Ziekenhuis Gent, Gent
Registry updated 2026-10-06

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error